Cristina Dealis

Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial

Carmelo Bengala, Federica Bertolini, N. Malavasi et al. · British Journal of Cancer · 2009 · 215 citations · Full text

Medicine, Oncology, Pharmacology +9

Prognostic and Predictive Value of Baseline and Posttreatment Molecular Marker Expression in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy

Federica Bertolini, Carmelo Bengala, Luisa Losi et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 107 citations · Full text

Medicine, Oncology, Surgery +17

Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer

Carmelo Bengala, Stefania Bettelli, Federica Bertolini et al. · Annals of Oncology · 2008 · 90 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Neoadjuvant Treatment With Single-Agent Cetuximab Followed by 5-FU, Cetuximab, and Pelvic Radiotherapy: A Phase II Study in Locally Advanced Rectal Cancer

Federica Bertolini, Silvana Chiara, Carmelo Bengala et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 84 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016

Roberta Rudà, Alessia Pellerino, Andrea Pace et al. · Journal of Neuro-Oncology · 2019 · 41 citations

Medicine, Oncology, Pharmacology +15